Microbix Biosystems Inc. (TSX:MBX)

Canada · Delayed Price · Currency is CAD

0.3000

+0.0100 (3.45%)

Oct 30, 2026, 3:59 PM EDT

Microbix Biosystems Financials Overview

Financials in millions CAD. Fiscal year is October - September.

Millions CAD. Fiscal year is Oct - Sep.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Revenue	15.4	18.59	25.39	16.51	19.08	18.59
Revenue Growth	-27.13%	-26.81%	53.77%	-13.43%	2.60%	76.66%
Gross Profit	7.07	9.85	15.39	7.48	11.12	11.04
Operating Income	-4.28	-1.58	3.9	-2.74	2.61	4.84
Net Income	-4.88	-2.25	3.52	-0.04	1.79	3.23
Earnings Per Share	-0.04	-0.02	0.03	-0.00	0.01	0.03
EPS Growth	-	-	-	-	-49.98%	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Product Sales	15.33	18.59	21.31	15.16	19.07	18.59
Licensing Fees and Royalties	-	-	4.09	1.35	0	0
Total	15.4	18.59	25.39	16.51	19.08	18.59

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Investments	7.16	12.11	12.96	11.61	13.49	9.99
Total Debt	6.72	6.77	6.4	6.65	5.82	7.74
Net Cash (Debt)	0.44	5.34	6.57	4.96	7.66	2.25
Net Cash Growth	-92.27%	-18.70%	32.41%	-35.30%	240.46%	-
Net Cash Per Share	0.00	0.04	0.05	0.04	0.05	0.02

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Operating Cash Flow	-3.29	-0.08	4.35	-1.09	3.47	2.11
Capital Expenditures	-0.6	-0.8	-1.64	-1.02	-2.03	-1.24
Free Cash Flow	-3.89	-0.88	2.71	-2.11	1.44	0.86
Free Cash Flow Growth	-	-	-	-	66.64%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Gross Margin	45.90%	53.02%	60.61%	45.30%	58.32%	59.40%
Operating Margin	-27.77%	-8.48%	15.35%	-16.57%	13.68%	26.01%
Pretax Margin	-32.08%	-12.38%	14.46%	-0.24%	9.78%	17.39%
Profit Margin	-31.72%	-12.08%	13.86%	-0.24%	9.38%	17.39%
FCF Margin	-25.25%	-4.72%	10.68%	-12.78%	7.55%	4.65%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Oct '26 Oct 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
PE Ratio	-	-	12.97	-	39.63	24.33
Forward PE	-	21.67	16.75	17.43	20.40	13.70
P/FCF Ratio	-	-	16.84	-	49.24	91.05
PS Ratio	2.67	1.99	1.80	2.53	3.72	4.23